PDS expand post-mortem software licensing options
now provide Internet access to its specialised post-mortem
functionality system to users that include University research
departments, CROs, Biotechs and smaller Toxicology and Pathology
work groups.
The service provides an advantage for customers that want to use this specialised software in a hosted and administration-free environment via the Internet, which also serves to provide access to data off-site and out of office hours
The introduction of these additional licensing options is PDS' take on providing a service that allows pharmaceutical companies and CROs to use the software without having to pay upfront costs.
In addition, these companies can incorporate a pay-as-they-go system without impacting their capital budgets.
The PathData software system is used for preclinical pathology, offering users post-mortem functionalities from necropsy and histology to microscopy, statistics, tables, peer review, imaging and FDA-compliant final report generation.
The ante-mortem aspects are backed up by the company's ToxData System for toxicology and clinical pathology and the new ReproData System for reproductive toxicology and teratology.
"Not only are research universities and CROs enthused about being able to utilise the same powerful and flexible mission-critical software that is used by 7 of the 10 Top-Ten Pharma companies but, interestingly enough, so are biotech companies," said Arthur Karakos, CEO of the vendor's North America marketing and support group, >Pathology Data Solutions.
